June 22, 2010 / 3:02 PM / 7 years ago

CANADA STOCKS-TSX pulled lower by U.S. data, commodity drop

 *TSX down 18.23 points, or 0.15 percent, at 11,917.85
 *Seven of index’s 10 main groups lower
 *Magna shares up 2 pct after report of shareholder vote  (Adds details, quotes)
 By Jennifer Kwan
 TORONTO, June 22 (Reuters) - Toronto’s resource-heavy main stock index stumbled on Tuesday morning, pushed lower by weak commodity-linked issues and by data that showed a surprise drop in U.S. home sales.
 In the index’s oil and gas group, Suncor Energy (SU.TO) was down 0.7 percent at C$34.29, and Encana Corp (ECA.TO) fell 0.7 percent to C$34.98. Miner First Quantum Minerals (FM.TO) fell 1.2 percent to C$63.80.
 Resource-linked shares dropped with oil and base metals prices as expectations grew that a slow rise in China’s yuan would have a more limited impact on demand than initially anticipated. [O/R] [MET/L]
 As well, U.S. data that showed existing home sales fell in May raised doubts about the pace of economic recovery [.N], said John Ing, president of Maison Placements Canada.
 “What’s happening is that evidence of a slowdown is increasing and that’s bothering investors because, as we know, the recovery is in a very fragile and tenuous state,” Ing said.
 At 10:25 a.m. (1425 GMT), the Toronto Stock Exchange’s S&P/TSX composite index .GSPTSE was down 18.23 points, or 0.15 percent, at 11,917.85, with seven of its 10 main sectors lower.
 Gold miners’ shares rose with bullion prices XAU=, which climbed in part on persistent euro zone debt concerns.[GOL/] World No. 1 gold producer Barrick Gold (ABX.TO) was up 0.9 percent at C$46.26, and Goldcorp (G.TO) was up 0.8 percent at C$45.69 as
 Shares of Magna International Inc MGa.TO climbed 2 percent to C$70.70. A majority of Magna shareholders have cast early votes in support of the auto-parts maker’s controversial plan to pay its founder a big premium to loosen his control, the Globe and Mail newspaper said on Tuesday. [ID:nN22114898]
 Drugmaker Biovail Corp BVF.TO was up 8.8 percent at C$18.51. The company announced on Monday it will take over U.S-based Valeant Pharmaceuticals International (VRX.N) in a complex deal that the companies said will position them better to serve the growing baby boomer market. [ID:nSGE65K07S]
 ($1=$1.02 Canadian)  (Reporting by Jennifer Kwan; editing by Peter Galloway)   

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below